Search Results

You are looking at 41 - 50 of 188 items for :

  • "lymph node dissection" x
  • Refine by Access: All x
Clear All
Full access

Bryan J. Schneider, Ashish Saxena, and Robert J. Downey

-year follow-up. This study randomized 144 patients with newly diagnosed operable SCLC to either pneumonectomy with lymph node dissection or thoracic radiation. Only approximately half of the patients assigned to the surgery arm underwent a complete

Full access

Robert J. Motzer, Neeraj Agarwal, Clair Beard, Graeme B. Bolger, Barry Boston, Michael A. Carducci, Toni K. Choueiri, Robert A. Figlin, Mayer Fishman, Steven L. Hancock, Gary R. Hudes, Eric Jonasch, Anne Kessinger, Timothy M. Kuzel, Paul H. Lange, Ellis G. Levine, Kim A. Margolin, M. Dror Michaelson, Thomas Olencki, Roberto Pili, Bruce G. Redman, Cary N. Robertson, Lawrence H. Schwartz, Joel Sheinfeld, and Jue Wang

BS Sheinfeld J . The current status of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ-cell tumors . Nat Clin Pract Urol 2005 ; 2 : 330 – 335 . 19 Davis BE Herr HW Fair WR . The management of patients with

Full access

Michael P. Porter and Paul H. Lange

renal cell carcinoma: Outcome and indication for adrenalectomy . J Urol 2004 ; 171 ( 6 Pt 1 ): 2155 – 2159 ; discussion, 2159 . 35 Blom JH van Poppel H Marechal JM . Radical nephrectomy with and without lymph node dissection: preliminary

Full access

Meaghan Tenney and Joan L. Walker

. Laparoscopic pelvic and paraaortic lymph node dissection in the obese . Gynecol Oncol 2002 ; 84 : 426 – 430 . 29 Frigerio L Gallo A Ghezzi F . Laparoscopic-assisted vaginal hysterectomy versus abdominal hysterectomy in endometrial cancer . Int J

Full access

Jennifer B. Ogilvie and Electron Kebebew

lymph node dissection in sporadic and hereditary medullary thyroid cancer . J Clin Endocrinol Metab 2003 ; 88 : 2070 – 2075 . 8. Quayle FJ Moley JF . Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes . J Surg Oncol 2005

Full access

Peter E. Clark, Philippe E. Spiess, Neeraj Agarwal, Matthew C. Biagioli, Mario A. Eisenberger, Richard E. Greenberg, Harry W. Herr, Brant A. Inman, Deborah A. Kuban, Timothy M. Kuzel, Subodh M. Lele, Jeff Michalski, Lance Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Jerome P. Richie, Wade J. Sexton, William U. Shipley, Eric J. Small, Donald L. Trump, Geoffrey Wile, Timothy G. Wilson, Mary Dwyer, and Maria Ho

/or vascular invasion, and therefore an inguinal lymph node dissection (ILND) should be recommended. 4 , 25 These factors can then further define patients into low-, intermediate-, and high-risk groups for lymph node metastasis. 18 , 60 , 61 The European

Full access

Michael D. Green and James A. Hayman

guidelines favor lymph node dissection more strongly in fit patients with clinically apparent disease versus those with clinically node-negative, SLNB-positive disease, but definitive RT can also be considered in both settings. The advantage of further

Full access

Benjamin E. Greer and Wui-Jin Koh

evaluation and sentinel lymph node biopsy (SLNB) or bilateral inguinofemoral lymph node dissection (LND). Lateral lesions should have ipsilateral groin node evaluation plus SLNB or ispsilateral groin LND. LND is performed through a separate incision, Dr

Full access

Ernest S. Han and Mark Wakabayashi

, pelvic and para-aortic lymph node dissection, and peritoneal biopsies and washings performed through a vertical midline incision. 2 – 4 When evidence of a metastatic tumor is present within the abdominal/pelvic cavity, tumor debulking is performed with

Full access

Daniel G. Coit and Anthony J. Olszanski

with lesions 0.76 to 1.0 mm, SLNB can be considered. For patients with lesions thicker than 1 mm, SLNB is recommended ( Figure 1 ). Patients with stage IIIA (sentinel lymph node-positive) disease should undergo completion lymph node dissection or be